Tag: PCa17
PCa17: What to expect in future prostate cancer management
The number of promising biomarkers at different molecular levels are increasing, accompanied by numerous testing in the market, but cancer experts say independent and prospective validation is crucial to help the medical community eventually provide optimal care to cancer...
PCa17: Interactive, compact meeting opens in Vienna
Challenges in diagnosis, staging and patient selection were among the issues taken up in the first plenary session of the EAU Update on Prostate Cancer (PCa17) opened in Vienna today. With more than 300 participants including faculty and exhibitors,...
Tumour characteristics and patient profile: Crucial issues in PCa treatment
Despite advances in diagnostic tools and imaging technologies, prostate cancer (PCa) management remains a challenge to many experts due to extensive variability in tumour characteristics and individual patient profiles which complicate the delivery of an optimal treatment plan. “There...